← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Canget Biotekpharma, Llc
Buffalo, NY
$2,951,288
Total funding
3
Grants
Funding over time
peak $988.3K · FY2014–23$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,951,288 · 3
By mechanism
R44$2,326,369 · 1
R43$624,919 · 2
Investigators at Canget Biotekpharma, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer$988,326
R44 · FY2016 · CA
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer$903,055
R44 · FY2015 · CA
Perform non-GLP and GLP TOX/TK studies, and file a novel drug IND with the FDA for advanced pancreatic cancer patient clinical trials$400,000
R43 · FY2023 · CA
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer$224,988
R44 · FY2014 · CA
A novel small molecule FL7N-1 for treating pediatric cancer retinoblastoma$224,919
R43 · FY2018 · CA
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer$210,000
R44 · FY2018 · CA